Hair Bell CAPILLAIRE
Food supplement declared in France, declaration No 2022-4-190, decision dated 6 April 2022
Hair Bell CAPILLAIRE (Institut Claude Bell) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Institut Claude Bell
- Food business operator placing the product on the market
- B2C
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Comprimé
- Daily dose
- 2 comprimés
- Directions for use
- Le matin avec un grand verre d'eau
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Cheveux et ongles
Declaration 325571, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa bambos (L.) Voss | Exsudat | Extrait sec aqueux | 50 mg |
| Citrus sinensis (L.) Osbeck | Fruit | Extrait sec aqueux | 40 mg |
| Malus pumila Mill. | Fruit | Extrait sec hydroalcoolique | 30 mg |
| Vaccinium myrtillus L. | Fruit | Extrait sec hydroalcoolique | 10 mg |
Other active ingredients
| Name | Per day |
|---|---|
| L-cystine | not declared |
| Pectine de pomme | not declared |
| Méthionine | not declared |
| Hydrolysat de collagène de poisson | not declared |
| Hydrolysat de kératine | not declared |
| Acide hyaluronique | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothénate de calcium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| Gluconate de cuivre | Cuivre | 5,000 µg | 2,000 µg |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
| Oxyde de zinc | Zinc | 25 mg | 15 mg |
Additives
E341, E504, E460, E470b
Other ingredients
Proteine de blé hydrolysée, Poudre de pomme
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Institut Claude Bell
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.